Feature | March 19, 2013 | Raissa Rocha

Advances in Digital Mammography

This article appeared as an introduction to a Comparison Chart on Digital Mammography Systems in the March 2013 issue.

Digital mammography systems

Photo courtesy of Hologic Inc.

Advances in digital mammography are evolving as clinicians look to improve breast cancer screening in women. In recent years, new technological trends have emerged; notably, the addition of 3-D breast imaging, or tomosynthesis, which was approved by the U.S. Food and Drug Administration (FDA) in 2011. But as technology improves, questions remain over the recommended frequency of screening for breast cancer.

A multicenter study published November 2012 in the journal Radiology found that adding tomosynthesis to standard digital mammography screening “significantly increases radiologists’ diagnostic accuracy while reducing false positive recall rates.” The results show that tomosynthesis can be used to address major concerns with mammography, particularly missed cancers and false positive rates, according to lead researcher Elizabeth A. Rafferty, M.D., director of breast imaging at the Avon Comprehensive Breast Center at Massachusetts General Hospital in Boston.

Breast tomosynthesis is a recent technology that captures multiple, low-dose images from different angles around the breast. The captured images are then produced into a 3-D reconstruction. Both digital mammography and breast tomosynthesis can be performed on the same equipment in rapid succession.

The study’s authors found that when compared to digital mammography alone, the use of the combined exam resulted in increased diagnostic accuracy for all participating radiologists. There also was a rate of increase in diagnostic sensitivity — the rate at which cancer present in the breast was correctly identified — and a decrease in false positive recall rates. “In the clinical setting, we would expect that type of reduction in recall rate to translate into a substantial number of unnecessary diagnostic tests being avoided,” said Rafferty.

Despite the evolution of conventional mammography and 3-D breast imaging, there are concerns about the frequency of examinations and the recommended age at which women should begin screening. Traditionally, routine screening mammography has been recommended annually for all women over 40. In 2009, the U.S. Preventive Services Task Force (USPSTF) issued new guidelines, recommending screening mammography every two years for women 50 to 74, citing concerns over false positive recall rates, radiation exposure and the potential for unnecessary follow-up exams that may be invasive. The American Cancer Society (ACS) continues to support the traditional recommendation of annual screening starting at 40.

At the 2012 meeting of the Radiological Society of North America (RSNA), researchers presented an analysis of the impact of the new USPSTF guidelines on women between 40 and 49. Researchers found that 19 percent of breast cancers detected — among 43,351 screening exams that were analyzed — were in women between 40 and 49. Of those cancers, more than 50 percent were found to be invasive.

“Nearly 20 percent of cancers detected with screening mammography were found among women in their 40s,” said researcher Elizabeth Arleo, M.D., assistant professor of radiology at NewYork–Presbyterian Hospital/Weill Cornell Medical College in New York City. “It seems unacceptable to potentially miss nearly 20 percent of the breast cancers we are identifying. Our data favor the [ACS] recommendations of annual mammograms starting at age 40.” 

The subject of potential “overdiagnosis” remains one of the key issues in digital mammography and breast tomosynthesis. The updated USPSTF guidelines reflected an evaluation of screening mammography as currently practiced in the United States, wrote Henry G. Kaplan, M.D., and Judith A. Malmgren, Ph.D., in the January 2013 issue of the Annals of Internal Medicine. The conclusion of the USPSTF was that there are more harms than benefits for women 40 to 49, and “that screening could be reduced to every other year for women 50 to 59 years,” Kaplan and Malmgren said.

While shown to have reduced death from breast cancer in populations that have routine screening, mammography also can be associated with needless work-ups and attendant complications, they noted. Patients may become distressed over waiting for follow-up and exam results, and “overdiagnosis” could lead to unnecessary tests and procedures, further driving up healthcare costs. Kaplan and Malmgren argued that instead of debating on the merits of early cancer screening, physicians should improve the treatment of early cancer found on mammography. “We believe that the term ‘overdiagnosis’ in the context of breast cancer places this problem in an appropriate light, suggesting that these patients do not have cancer,” they said.

The advantage of routine screening mammography is to detect cancers early before they become invasive. Early detection reduces the need for aggressive chemotherapy or radiotherapy. But many see frequent mammograms as resulting in high recall rates and benign biopsy results, adding more anxiety for patients. “The conundrum is that to save lives and reduce treatment-related toxicity, tumors need to be found at an early, more treatable stage,” Kaplan and Malmgren wrote.

Despite these debates, digital mammography continues to make advances as companies work to improve their technologies. The addition of breast tomosynthesis to traditional 2-D mammograms improves the diagnostic accuracy of exams, ultimately resulting in better patient care.   itn

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Breast imaging X-ray mammogram showing a breast tumor. Photo courtesy of Monthian Ritchan-Ad

Photo courtesy of Monthian Ritchan-Ad

Feature | Breast Density | September 08, 2017 | By Roy Prager, M.D.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with...
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Top list of stories, article, videos for breast imaging.
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
Overlay Init